| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |